Nattokinase: What the Evidence Actually Says About This Blood-Clot-Dissolving Enzyme

Nattokinase: What the Evidence Actually Says About This Blood-Clot-Dissolving Enzyme

In 1987, a Japanese scientist named Hiroyuki Sumi noticed something strange: when he dropped a fermented soybean food called natto onto a plate of clotted blood, the clot began to dissolve. The substance responsible — an enzyme he named nattokinase — has since become one of the most popular "natural blood thinner" supplements in the world, marketed on the idea that it clears the arteries and helps you live longer. Thirty years and dozens of clinical trials later, the real picture is more interesting: nattokinase does lower blood pressure, but its effect on the arteries themselves is shakier than the marketing suggests.

Evidence Tier: 🥈 Silver — real randomized human trials and a meta-analysis, but mixed results: solid for blood pressure, null for artery hardening, and zero direct longevity data.

⚖️ At a Glance: Pros & Cons

⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking any supplement. The information below is for education only.

📋 Simple Summary

Nattokinase is an enzyme — a small protein that speeds up a chemical reaction — that comes from natto, a traditional Japanese food made by fermenting soybeans with a friendly bacteria. Its main talent is dissolving fibrin, the sticky mesh your body uses to build blood clots. Because of that, it's sold as a natural way to prevent heart attacks and strokes. The honest news from the research: nattokinase does reliably lower blood pressure a little — by about 3.5 points on the top number — and it does make the blood slightly less likely to clot. But the best long-term study found it did not actually slow the hardening of artery walls, and no study has shown it helps anyone live longer. Our verdict: a reasonable, well-tolerated cardiovascular supplement, especially if your blood pressure is creeping up — but it's not a magic artery-cleaner, and it's not a longevity drug.

What Is Nattokinase?

Nattokinase is a fibrinolytic enzyme — that is, a protein that breaks down fibrin. Fibrin is the thread-like protein that weaves itself into a mesh to form the scaffolding of a blood clot; it's what makes a clot hold together. Nattokinase's name comes from "natto" (the food) plus "kinase" (a suffix for enzymes). It is produced by Bacillus subtilis natto, the bacteria used to ferment soybeans into natto, a stringy, strong-smelling breakfast staple eaten in Japan for over a thousand years.

Dr. Hiroyuki Sumi discovered it almost by accident in 1987 while testing traditional foods for clot-dissolving activity. He found that natto extract dissolved an artificial blood clot more potently than many existing fibrin-dissolving drugs — and, importantly, its effect lasted for hours in the body, far longer than injected clot-busters. That longevity of action (no pun intended) is why nattokinase caught the eye of researchers rather than staying a food-science curiosity.

How It Works

Nattokinase has two main jobs in the body, and they explain both its benefits and its limits:

1. It dissolves fibrin directly. Blood clots are made of fibrin strands. Nattokinase cuts those strands apart — it's a "fibrinolytic" enzyme, working a bit like the clot-busting drugs given after a stroke, but taken by mouth and far milder. It also appears to boost your body's own clot-clearing system (converting plasminogen to plasmin, the enzyme that naturally dissolves clots). In lab and animal studies this is unambiguous: nattokinase clearly breaks down clots. In a 2025 mouse study, it reduced tail-thrombus size by about 42%.

2. It releases blood-pressure-lowering peptides. When nattokinase is digested, it breaks into small protein fragments. Some of these fragments block the enzyme ACE (angiotensin-converting enzyme), the same target as common blood-pressure drugs like lisinopril. A 2026 study identified two specific ACE-blocking peptides from nattokinase. This is likely why nattokinase lowers blood pressure independently of its clot-dissolving action.

The catch — and it's a big one — is that nattokinase is a protein. Proteins are chewed up by stomach acid and digestive enzymes before they can reach the bloodstream. This is why its clot-dissolving power, so obvious in a test tube, is harder to demonstrate in people, and why the clinical results below are more modest and more mixed than the "natural blood thinner" label implies.

The Longevity Connection

🥈 Blood pressure (human evidence — the strongest finding): High blood pressure is the single most important modifiable risk factor for heart attack, stroke, and premature death. A 2023 meta-analysis of six randomized controlled trials (546 participants) found nattokinase lowered systolic blood pressure by 3.45 mmHg and diastolic by 2.32 mmHg, with high statistical confidence. A separate North American multicenter trial (Jensen et al., 2016) found similar effects in a hypertensive population, with the clearest reductions in men. This is real — but modest. It's roughly what you'd get from cutting back on salt or losing a few pounds, not from a prescription drug.

🥈 Clotting (human evidence — real but mild): In a 2019 randomized trial of 100 people with high cholesterol, eight weeks of nattokinase significantly lengthened two measures of clotting time. This confirms nattokinase genuinely thins the blood a little — which is exactly why it interacts with prescription blood thinners and must be stopped before surgery.

⚠️ Atherosclerosis (human evidence — the key negative): The NAPS trial, the largest and longest study to date (265 adults, median age 65, three years of follow-up), measured artery-wall thickness and stiffness with serial ultrasounds. Nattokinase did nothing: no difference from placebo on any measure. A smaller 2017 Chinese study did report reduced carotid plaque with nattokinase versus a statin, but that result has not been replicated, and the better-controlled trial says null. If your goal is to "unclog your arteries," the best evidence says nattokinase won't do it.

🥉 Brain and other organs (early, mostly animal): A 2026 trial in 120 people with narrowed carotid arteries found no improvement in overall cognition, but a small signal for better visuospatial function. In animals, nattokinase promoted brain-cell growth after stroke (via a hormone called irisin) and protected against diabetic eye damage — intriguing, but not yet demonstrated in humans.

⚠️ Longevity itself (no direct evidence): There is exactly zero human data showing nattokinase extends lifespan or healthspan. The longevity argument is indirect: lower blood pressure and a lower clotting tendency plausibly reduce cardiovascular events, and cardiovascular disease is the leading cause of death. That's a reasonable inference — but it is an inference, not a finding.

Key Studies

Dosing and Safety

How to take it: Nattokinase is typically taken on an empty stomach, often in the morning, because food and stomach acid can further degrade the enzyme. Doses are measured in "fibrinolytic units" (FU), a measure of clot-dissolving activity, or occasionally in milligrams.

Form: Choose a product labeled with its activity in FU (fibrinolytic units), not just milligrams, so you know how active the enzyme actually is. A common, well-studied form is "NSK-SD," a nattokinase extract with vitamin K2 removed — this matters because natto naturally contains vitamin K2, which promotes clotting and would work against nattokinase's blood-thinning effect.

Side effects: In clinical trials nattokinase is generally very well tolerated, with few side effects beyond occasional mild stomach upset. The one serious concern is bleeding: because it thins the blood, it can increase bruising and, in rare cases, contribute to bleeding events.

The drug-interaction warning (important): Do not take nattokinase alongside prescription blood thinners (warfarin, apixaban, rivaroxaban, clopidogrel) or other anticoagulant supplements (high-dose fish oil, ginkgo, garlic extract) without your doctor's input — the effects can stack and raise bleeding risk. Stop it at least two weeks before any surgery, and tell your anesthesiologist. A 2025 review specifically flagged nattokinase among anti-atherosclerotic supplements that carry bleeding and drug-interaction risks.

❓ Common Questions About Nattokinase

The Bottom Line

Where the evidence ranks: Nattokinase sits in the middle of the supplement pack — better studied than most, but with a narrower benefit than its marketing implies. The blood-pressure effect is real, reproducible, and confirmed by a meta-analysis, but it's modest (a few mmHg). The anti-clotting effect is real but mild. The "cleans your arteries" and "prevents heart attacks" claims, however, run ahead of the evidence: the best long-term trial found no effect on artery hardening, and no study has shown a reduction in actual heart attacks, strokes, or death.

Our verdict: Nattokinase is a reasonable, well-tolerated supplement for someone whose blood pressure is creeping up or who wants gentle cardiovascular support — and who isn't already on blood thinners. It is not a substitute for exercise, diet, or blood-pressure medication, and it is not a longevity drug. If you take it, treat it as a small supporting player in a larger cardiovascular plan, not the main event.

Who it's for: People with mildly elevated blood pressure or a family history of clotting, who understand the evidence is modest and the bleeding-interaction risk is real. If you take prescription blood thinners, this supplement is not for you.

Medical Disclaimer: This page is for educational purposes only and is not medical advice. Nattokinase is a supplement, not a treatment for any disease, and it can interact dangerously with blood-thinning medications. Always consult a qualified healthcare professional before starting any supplement, especially if you take medication or have a medical condition.

Sources

1. Zhou et al. Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Rev Cardiovasc Med. 2023. PMID 39076715
2. Jensen GS, et al. Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor. Integr Blood Press Control. 2016. PMID 27785095
3. Kim ES, et al. Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clin Hemorheol Microcirc. 2021. PMID 33843667
4. Fan et al. Lipid-lowering, antihypertensive, and antithrombotic effects of nattokinase combined with red yeast rice in patients with stable coronary artery disease. Front Nutr. 2024. PMID 38812930
5. The Effect of Nattokinase-Monascus Supplements on Dyslipidemia: A Four-Month RCT. Nutrients. 2023. PMID 37836525
6. Nattokinase supplementation for cognitive enhancement in asymptomatic intracranial/carotid stenosis (ICC-PACS). J Stroke Cerebrovasc Dis. 2026. PMID 41325794
7. Chen et al. A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia. Zhonghua Yi Xue Za Zhi. 2017. PMID 28763875
8. Jang et al. The effects of nattokinase supplementation on hemostatic factors in nondiabetic hypercholesterolemic subjects. Food Funct. 2019. PMID 31070609
9. Weng Y, et al. Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease. Int J Mol Sci. 2017. PMID 28264497
10. Nattokinase as an adjuvant therapeutic strategy for non-communicable diseases: a review. Expert Rev Cardiovasc Ther. 2024. PMID 39404094
11. Data Recorded in Real Life Support the Safety of Nattokinase in Patients with Vascular Diseases. Nutrients. 2021. PMID 34199189
12. Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks. Int J Mol Sci. 2025. PMID 41155474
13. Nattokinase Promotes Post-stroke Neurogenesis and Cognition Recovery via Increasing Circulating Irisin. J Agric Food Chem. 2023. PMID 37466380
14. Protective effects of nattokinase against microvasculopathy and neuroinflammation in diabetic retinopathy. J Diabetes. 2023. PMID 37403338
15. Ameliorated effects of nattokinase on high-fat diet and carrageenan-induced tail-thrombosis mice. J Sci Food Agric. 2025. PMID 40637357